ABSTRACT. The present study identified the proteins that are differentially expressed during ischemic brain injury. Adult male rats were performed a middle cerebral artery occlusion (MCAO) to induce cerebral ischemia, and brains were collected at 24 hr after MCAO. Protein analysis was performed on the cerebral cortex using two-dimensional gel electrophoresis. Protein spots with a greater than 3 fold change in intensity between the sham and MCAO groups were identified by mass spectrometry. Among these proteins, 60 kDa heat shock protein, dehydropyrimidinase-related protein 2, t-complex protein 1, and Rho GDP dissociation inhibitor levels were significantly increased in MCAO group compared to those of the sham group. In contrast, thioredoxin, peroxiredoxin-2, stathmin, ubiquitin carboxyterminal hydrolase L1, guanine nucleotide-binding protein , pyridoxal-5'-phosphate phosphatase, and apoplipoprotein A-I levels were significantly decreased in MCAO group. These results suggest that cerebral ischemia induces neuronal cells death by changing expression levels of several proteins. Neurodegenerative disorders including Alzheimer's disease, Parkinson's disease and stroke are a major cause of adult disability and mortality. Among these disorders, stroke is a serious cerebrovascular disorder and the most common cause of death. A previous study demonstrated that cerebral ischemia in an experimental stroke model involves apoptotic and survival signaling pathways and leads to neuronal cells death [24] . Oxidative stress, metabolic compromise, and mitochondrial dysfunction may trigger neuronal apoptosis in neurodegenerative disorders [17] . The mechanisms of neuronal cell death are very complex and vague. At present, little is known about the changes in protein expression in damaged brain region during ischemic injury. The purpose of this study was to investigate these changes in expression in the cerebral cortex following ischemic brain injury.
Neurodegenerative disorders including Alzheimer's disease, Parkinson's disease and stroke are a major cause of adult disability and mortality. Among these disorders, stroke is a serious cerebrovascular disorder and the most common cause of death. A previous study demonstrated that cerebral ischemia in an experimental stroke model involves apoptotic and survival signaling pathways and leads to neuronal cells death [24] . Oxidative stress, metabolic compromise, and mitochondrial dysfunction may trigger neuronal apoptosis in neurodegenerative disorders [17] . The mechanisms of neuronal cell death are very complex and vague. At present, little is known about the changes in protein expression in damaged brain region during ischemic injury. The purpose of this study was to investigate these changes in expression in the cerebral cortex following ischemic brain injury.
MATERIALS AND METHODS
Experimental animals: Male Sprague-Dawley rats (225-250 g, n=40) were purchased from Samtako Co. (Animal Breeding Center, Osan, Korea) and were randomly divided into two groups, sham-operated group and middle cerebral artery occlusion (MCAO)-operated group (n=20 per group). Animals were maintained under controlled temperature (25C) and lighting (14L:10D), and allowed free access to food and water. All animal experiments were carried out in accordance with the Guide for care and use of laboratory animals, and use of Gyeongsang National University.
Middle cerebral artery occlusion: The MCAO model was prepared following the previously described method of intra-luminal vascular occlusion [16] . Animals were anesthetized with sodium pentobarbital (100 mg/kg). The right common carotid artery, internal carotid artery, and external carotid artery were exposed through a midline cervical incision. A 4/0 monofilament nylon was inserted from the external carotid artery into the lumen of the internal carotid artery until it obstructed the origin of the middle cerebral artery. At 24 hr after MCAO, animals were decapitated and brains were removed. These brains were cut into 2 mm thick coronal slices and these slices were incubated for 20 min in a 2% triphenyltetrazolium chloride (TTC; Sigma, St. Louis, MA, U.S.A.) and fixed in 10% formalin. The stained slices were photographed by a Nikon CoolPIX990 digital camera (Nikon, Tokyo, Japan).
Two-dimensional gel electrophoresis: The right cerebral cortex samples (n=3) were pooled to minimize the response variation to MCAO among animals. The samples were homogenized in lysis buffer (8 M urea, 4% CHAPS, ampholytes, and 40 mM Tris-HCl) and centrifuged at 16,000  g for 20 min at 4C. The total protein concentration was determined using the Bradford method (Bio-Rad, Hercules, CA, U.S.A.) according to the manufacturer's protocol. The proteins were separated by the two-dimensional (2D) gel electrophoresis. Briefly, prior to isoelectric focusing (IEF), the immobilized pH gradients (IPG, pH 4-7, 17 cm, Bio-Rad) gel strips were re-hydrated in sample buffer(8 M urea, 2% CHAPS, 20 mM DTT, 0.5% IPG buffer, bromophenol blue) that contained sample proteins for 13 hr. IEF was carried out in three steps: 250 V (15 min), 10,000 V (3 hr), and then 10,000 V to 50,000 V using Protean IEF Cell (Bio-Rad). For SDS gel electrophoresis, gradient gels (7.5-17.5%) were prepared. After equilibration of the isoelectric focusing strips, 2D gel electrophoresis was carried out using Protein-II XI electrophoresis equipment (BioRad) at 10C. Current conditions were 5 mA per gel for 2 hr and followed by 10 mA per gel for 10 hr. The gels were fixed in a solution (12% acetic acid, 50% methanol) for 2 hr, washed in 50% ethanol for 20 min, and then treated in 0.2% sodium thiosulfate for 1 min. The gels were impregnated in a silver solution (0.2% silver nitrate, 0.75 ml/l formaldehyde) for 20 min, and washed with deionized water. The gel was developed in a solution (0.2% sodium carbonate, 0.5 ml/l formaldehyde) and the reaction was stopped by stop solution (1% acetic acid).
Image analysis and protein identification: The silver stained gels were scanned using Agfar ARCUS 1200 TM (Agfar-Gevaert, Mortsel, BEL). The scanned gel images were analyzed using a standard protocol for PDQuest software (Bio-Rad). Protein spots with a greater than 3 fold change in intensity were identified in sham and MCAO groups. The gel pieces containing the desired protein spots were excised and distained. The gel particles were incubated with reduction solution and alkylation solution for 30 min, and followed by trypsin-containing digestion buffer. The extract peptides were analyzed in a Voyager-DE TM STR biospectrometry workstation (Applied Biosystem, Forster city, CA, U.S.A.) for MALDI-TOF mass spectrometery. Proteins were identified using search programs MS-Fit and ProFound program. SWISS-PROT and NCBI were used as the protein sequence databases.
Western blot analysis:
Total protein (30 g) was applied to each lane on to 10% SDS-polyacrylamide gels. Electrophoresis and immunoblotting were performed and the polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, U.S.A.) were washed in Tris-buffered saline containing 0.1% Tween-20 (TBST) and then incubated with anti-60 kDa heat shock, anti-thioredoxin, and anti-peroxiredoxin-2 antibody (diluted 1:1,000, Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), as primary antibody. And the membrane was incubated with secondary antibody (1:5,000, Pierce, Rockford, IL, U.S.A.) and signals were detected by ECL Western blot analysis system (Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.) according to the manufacturer's protocol.
Data analysis: All data are expressed as mean  SEM. The intensity analysis of protein spots and Western blot analysis were carried out using SigmaGel 1.0 (Jandel Scientific, San Rafael, CA, U.S.A.) and SigmaPlot 4.0 (SPSS Inc., Point Richmond, CA, U.S.A.). The ratio of intensity is described as spots intensity of MCAO-operated animal to spots intensity of sham-operated animal. The results in each group were compared by Student's t-test. The difference for comparison was considered significant at P<0.05.
RESULTS
TTC staining showed that MCAO induces serious brain damage (Fig. 1) . MCAO animals showed an increased infarct area while sham animals showed no infarct. Figure 2 illustrates two-dimensional electrophoresis (2-DE) maps in the range pH 4-7 for the cerebral cortices of sham and MCAO animals. Approximately 980 protein spots were observed in each image. We detected 14 spots with a more than three-fold change in intensity. Among these, 11 were clearly identified by MALDI-TOF analysis with 29-50% sequence coverage ( Table 1 ). The 60 kDa heat shock protein (Hsp60), dehydropyrimidinase-related protein 2 (DRP-2), t-complex protein 1 (TCP-1), and Rho GDP dissociation inhibitor (GDI) levels were significantly increased in MCAO animals compared to those of the sham animals. In contrast, thioredoxin, peroxiredoxin-2, stathmin, ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), guanine nucleotide-binding protein (G protein) , pyridoxal-5'-phosphate phosphatase (PLPP), and apoplipoprotein A-I levels were significantly decreased in MCAO animals. Two unknown proteins also decreased in MCAO animals, while one unknown protein was increased. Western blot analysis demonstrated that Hsp60 levels were significantly increased in MCAO-operated animals compared to that in sham-operated animals. However, peroxiredoxin-2 and thioredoxin levels were significantly decreased in MCAO-operated animals (Fig. 3) .
DISCUSSION
This study confirmed that MCAO induces serious brain damage. We identified 14 differentially-expressed proteins by MALDI-TOF analysis following ischemic brain injury. Hsp60 and DRP-2 are significantly increased in ischemic brain injury. Heat shock proteins are molecular chaperones which assist in new protein folding and processing. HSP60 is a stress-inducible mitochondrial matrix protein that is important for mitochondrial protein folding and function [11, 12] . Cerebral ischemia is associated with Hsp60 induction, and ischemic brain injury induces a toxic accumulation of unfolded proteins, leading to cell death [12] . Hsp60 levels increase after focal cerebral ischemia [12] , thus it is a marker of mitochondrial stress and damage severity after ischemic brain injury. DRP-2 is also known as collapsing response mediator protein 2. DRP-2 is expressed in the developing cerebral cortex and neocortical neurons and is involved in axonal growth and neuronal differentiation [20] . DRP-2 is up-regulated after focal cerebral ischemia in rats [4] , indicating active neurogeneration and repair after cere- bral ischemia. Similar to previous studies, our results show that Hsp60 and DRP-2 levels are significantly increased in ischemic brain injury. This study clearly confirmed the increase of Hsp60 levels in brain injury using Western blot analysis. Moreover, TCP-1 is mainly involved in cytoskeletal functioning by assisting in tubulin and actin folding, the main structural proteins in the brain [23] . This study shows that TCP-1 levels are increased in ischemic brain injury, representing a compensatory cellular mechanism to recover cytoskeletal damage. Thioredoxin, a redox protein, inhibits apoptosis and protects against oxidative stress [10, 26] . Thioredoxin overexpression decreases brain damage against focal cerebral ischemia and protects against oxidative stress [10, 26] . Peroxiredoxin-2 has thioredoxin-dependent peroxidase activity utilizing thioredoxin and thioredoxin reductase as electron donors for anti-oxidation. Peroxiredoxin-2 protects cortical neurons from oxidative stress and exerts a neuroprotective effect in ischemic brain injury [2] . Moreover, Western blot analysis clearly demonstrated that thioredoxin and peroxiredoxin-2 levels are markedly decreased in ischemic brain injury. Thus, thioredoxin and peroxiredoxin-2 down-regulation may mediate cell death in ischemic brain injury.
Stathmin has a critical role in cell stabilization and is involved in cell proliferation and differentiation [19] . The decrease of stathmin induces neuronal degradation [14] . This study demonstrated that stathmin levels are significantly decreased in ischemic brain injury, distorting the stabilization of cellular structure and inducing cell death. Ubiquitin plays a critical role in various cellular processes Fig. 2 . Two-dimensional SDS-PAGE analysis of proteins in the cerebral cortex from sham (A) and MCAO-operated (B) animals. Isoelectric focusing was performed at pH 4-7 using IPG strips, followed by second-dimensional separation on 7.5-17.5% gradient SDS gels stained with silver. Squares indicate the protein spots that were differentially expressed between sham and MCAO-operated groups. including cell differentiation, stress response, and apoptosis [21] . UCH-L1 attenuates neuronal cell death from oxidative stress, and a UCH-L1 decrease induces neuronal degeneration in neurodegenerative disease [5, 21] . The reduction of UCH-L1 induces a malfunction of the de-ubiquitination and ubiquitination mechanisms, sequentially leading to apoptosis [25] . The present study showed a UCH-L1 decrease in brain ischemia, possibly inducing neuronal cell death.
G-proteins consist of , , and  subunits and mediate the effects of extracellular stimuli including hormones and neurotransmitters [15] . G-proteins  binds GTP and regulates adenyl cyclase activity. Decreased G-proteins  levels indicate adenyl cyclase and protein kinase inactivation. This study showed that G-proteins  levels are significantly decreased in ischemic brain injury, mediating neuronal cell death. Rho GTPase is a GTP-binding protein that plays a pivotal role in regulating actin cytoskeletal organization, cell cycle progression, and apoptosis [3, 9] . In the central nervous system, Rho GTPase modulates neuronal growth and regulates neuronal survival [8] . Rho GTPase down-regulation is associated with increased neuronal apoptosis [6] . Rho GDP dissociation inhibitor (GDI) negatively regulates Rho GTPase activity. Increased GDI indicates Rho GTPase inactivation [3] . This study showed that GDI levels are increased in ischemic brain injury. Thus, we suggest that Rho GTPase down-regulation by GDI activation in ischemic brain injury mediates neuronal cell death. Pyridoxal-5'-phosphate (PLP) is the active coenzyme form of vitamin B6 and is a cofactor in neurotransmitter synthesis [1] . PLP phosphatase (PLPP) regulates PLP concentration [13] and is an actin-depolymerizing factor that is fundamental in cellular structure remodeling, cell growth, differentiation, and neurotransmission [7] . This study showed that PLPP levels are significantly decreased in ischemic brain injury. The reduction of PLPP may induce cell death. Additionally, apolipoprotein A-I is a major protein component of high-density lipoprotein in serum, with anti-inflammatory activity in inflammatory responses [18] . It protects kidney tissue from ischemic injury by inhibiting inflammatory cytokine release [22] . This study demonstrated that apolipoprotein A-I levels are significantly decreased in ischemic brain injury possibly activating inflammatory activity and inducing cell death.
In summary, ischemic brain injury induces neuronal cell death by modulating several proteins. This study shows that cerebral ischemic injury decreases thioredoxin, peroxiredoxin-2, stathmin, UCH-L1, G protein , PLPP, and apolipoprotein A-I levels. In contrast, Hsp60, DRP-2, TCP-1, and GDI levels are significantly increased in ischemic brain injury. These results provide evidence that ischemic brain injury induces the up-and down-regulation of specific proteins which mediate neuronal cell death. This study may provide valuable evidence for understanding neuronal cell death mediated by ischemic brain injury. 
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